Posted inBusiness AstraZeneca, Daiichi Sankyo antibody-drug conjugate Dato-DXd gains FDA nod Posted by admin January 17, 2025No Comments [ad_1] AstraZeneca, Daiichi Sankyo antibody-drug conjugate Dato-DXd gains FDA nod [ad_2] admin View All Posts Post navigation Previous Post Alignment Healthcare is latest to sue Medicare over Star RatingsNext PostU.S. oil and gas rig count slides to lowest in more than three years